Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABEMACICLIB Cause Clostridium difficile infection? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Clostridium difficile infection have been filed in association with ABEMACICLIB (Verzenio). This represents 0.1% of all adverse event reports for ABEMACICLIB.

15
Reports of Clostridium difficile infection with ABEMACICLIB
0.1%
of all ABEMACICLIB reports
1
Deaths
11
Hospitalizations

How Dangerous Is Clostridium difficile infection From ABEMACICLIB?

Of the 15 reports, 1 (6.7%) resulted in death, 11 (73.3%) required hospitalization, and 1 (6.7%) were considered life-threatening.

Is Clostridium difficile infection Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABEMACICLIB. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does ABEMACICLIB Cause?

Diarrhoea (4,988) Fatigue (1,878) Nausea (1,682) Vomiting (943) Malignant neoplasm progression (890) Decreased appetite (744) Death (696) Asthenia (678) Drug ineffective (668) White blood cell count decreased (566)

What Other Drugs Cause Clostridium difficile infection?

ADALIMUMAB (1,502) INFLIXIMAB (1,419) VEDOLIZUMAB (1,130) LENALIDOMIDE (814) VANCOMYCIN (743) METRONIDAZOLE (619) PREDNISONE (618) METHOTREXATE (588) RITUXIMAB (532) CIPROFLOXACIN (508)

Which ABEMACICLIB Alternatives Have Lower Clostridium difficile infection Risk?

ABEMACICLIB vs ABILIFY ABEMACICLIB vs ABIRATERONE ABEMACICLIB vs ABIRATERONE\ABIRATERONE ABEMACICLIB vs ABOBOTULINUMTOXINA ABEMACICLIB vs ABRAXANE

Related Pages

ABEMACICLIB Full Profile All Clostridium difficile infection Reports All Drugs Causing Clostridium difficile infection ABEMACICLIB Demographics